Embracing the failures of biotechnology Carl LeBel, Entrepreneur in Residence , Northeastern University 121 Snell Library — NEU April 12, 2017 4:00 pm posted in: CaNCURE Professional Development Activity|Joint CaNCURE and Nanomedicine Academy Seminar...
Blood trails: nanotechnology-enabled biomarker quantification for early disease detection 121 Snell Library — NEU October 13, 2017 3:25 pm posted in: Joint CaNCURE and Nanomedicine Academy Seminar Pharmaceutical Development of Fluorous Nanocolloids for...
Progress Towards Rational Cancer Therapy 121 Snell Library — NEU November 10, 2017 3:25 pm posted in: Joint CaNCURE and Nanomedicine Academy Seminar Nanomedicine in Cancer 121 Snell Library — NEU November 3, 2017 3:25 pm posted in: Joint CaNCURE and...
Engineering Nanoparticles for Intracellular delivery of proteins for cancer therapy and genome editing Qiaobing Xu, Ph.D. Associate Professor, Department of Biomedical Engineering, Tufts University 121 Snell Library — NEU January 16, 2018 3:25 pm posted...
Tackling the Physiological Barriers for Tumor-Targeted Drug Delivery Sijumon Kunjachan, Ph.D. Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School 121 Snell Library — NEU February 13, 2018 3:25 pm posted in: Joint CaNCURE and...
Three Start-ups: Contrasts in Trajectories, Challenges and Business Models Bonnie Fendrock Co-founder and CEO at Cyta Therapeutics, Inc. 121 Snell Library — NEU March 23, 2018 3:25 pm posted in: Joint CaNCURE and Nanomedicine Academy Seminar Nanomagnetic...
